CAS: 116686-15-8 - 4-Acetyl-2-(2,4-difluorophenoxy)methanesulfonanilide
Fórmula:C15H13F2NO4S
InChI:InChI=1/C15H13F2NO4S/c1-9(19)10-3-5-13(18-23(2,20)21)15(7-10)22-14-6-4-11(16)8-12(14)17/h3-8,18H,1-2H3
- Sinónimos:
- Fk-3311
- 3-(2,4-Difluorophenoxy)-4-(methanesulfonamido)acetophenone
- N-[4-Acetyl-2-(2,4-difluorophenoxy)phenyl]methanesulfonamide
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
Methanesulfonamide, N-[4-acetyl-2-(2,4-difluorophenoxy)phenyl]- REF: IN-DA000CZWCAS: 116686-15-8 | 98% | A consultar | Mar 10 Dic 24 | |
FK 3311 REF: TM-T7207CAS: 116686-15-8 | 97.3% | 45,00 €~535,00 € | Mar 17 Dic 24 | |
N-[4-Acetyl-2-(2,4-difluorophenoxy)phenyl]-methanesulfonamide REF: 3D-FA98753CAS: 116686-15-8 | Min. 95% | A consultar | Mar 21 Ene 25 |
Methanesulfonamide, N-[4-acetyl-2-(2,4-difluorophenoxy)phenyl]-
CAS:116686-15-8
Fórmula:
C15H13F2NO4S
Pureza:
98%
Forma y color:
Solid
Peso molecular:
341.3298
Ref: IN-DA000CZW
5mg | 160,00 € | ||
10mg | 175,00 € | ||
25mg | 479,00 € | ||
50mg | 576,00 € | ||
100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
FK 3311
CAS:116686-15-8
FK 3311 (COX-2 Inhibitor V) is a cell permeable and orally available sulfonanilide that acts …
Fórmula:
C15H13F2NO4S
Pureza:
97.3%
Forma y color:
Solid
Peso molecular:
341.33
Ref: TM-T7207
2mg | 45,00 € | ||
5mg | 66,00 € | ||
10mg | 94,00 € | ||
25mg | 162,00 € | ||
50mg | 246,00 € | ||
100mg | 365,00 € | ||
200mg | 535,00 € | ||
1mL*10mM (DMSO) | 89,00 € |
Entrega estimada en Estados Unidos, el Martes 17 de Diciembre de 2024
N-[4-Acetyl-2-(2,4-difluorophenoxy)phenyl]-methanesulfonamide
CAS:116686-15-8
N-[4-Acetyl-2-(2,4-difluorophenoxy)phenyl]-methanesulfonamide (NAPM) is a chiral, analgesic that has been shown to have antiinflammatory activity. NAPM …
Fórmula:
C15H13F2NO4S
Pureza:
Min. 95%
Peso molecular:
341.33 g/mol
Ref: 3D-FA98753
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025